(Basel) 8, 1178
Its best to consult with a healthcare provider to pick the GLP-1 medication thats most suitable for you
Rosenstock J, Frias J, Jastreboff AM et al (2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Protein amplifies what training does.The medication is the behavior-change tool that makes the deficit sustainable, not the intervention that determines what is lost during the deficit
Best for: Busy schedules or low appetite days Quick, no-prep protein intake Maintaining consistency when routine is disrupted Choosing the right type comes down to what you can take consistently